论文部分内容阅读
目的观察平郁石乳方联合化疗治疗三阴乳腺癌术后的临床疗效。方法:将137例三阴乳腺癌术后患者随机分类法分为2组:1对照组67例,AC-T化疗;2联合治疗组70例,平郁石乳方联合AC-T治疗。观察治疗中患者的临床表现和生存质量差别。结果:两组在消除临床症状和提高生存质量方面存在差异,差异有统计学意义(P<0.05)。结论:平郁石乳方联合化疗治疗三阴乳腺癌术可明显改善患者生活质量。
Objective To observe the clinical effect of Pingyu stone combined with chemotherapy in the treatment of triple negative breast cancer. Methods: A total of 137 patients with triple-negative breast cancer were randomly divided into 2 groups: 1 control group (67 cases), AC-T chemotherapy group (2), 70 combined treatment group (2) and Pingyu stone emulsion combined with AC-T treatment. Observed in the treatment of patients with clinical manifestations and quality of life difference. Results: There was a significant difference between the two groups in eliminating clinical symptoms and improving quality of life (P <0.05). Conclusion: Pingyu stone combined with chemotherapy in the treatment of triple negative breast cancer patients can significantly improve the quality of life of patients.